The US Food & Drug Administration (FDA) has communicated that it is exercising discretion to suspend enforcement of in-person dispensing requirements and in-person requirements related to the mifepristone Patient Agreement Form, provided other requirements are met.
To learn more about options for mail delivery to patients requiring mifepristone 200mg tablets, contact us.
